Desiree Weiberg

Papers

1

Total Citations

3

H-Index

1

About

Desiree Weiberg is a pioneering researcher in the field of urologic oncology, with a specialized focus on advancing surgical techniques for prostate cancer. Her work centers on the integration of nuclear medicine and robotic surgery, particularly through prostate-specific membrane antigen (PSMA)-targeted radioguided surgery (RGS). Her most notable contribution is the first feasibility study of a novel drop-in gamma probe for real-time lymph node detection during robot-assisted radical prostatectomy. This work, published in 2024, demonstrates how PSMA-targeted tracers can guide surgeons to remove cancerous lymph nodes with unprecedented precision, potentially reducing recurrence rates. Although her work is early-stage, with her top-cited paper accumulating 3 citations, its impact is rapidly growing within the surgical oncology community. Weiberg’s research bridges a critical gap between diagnostic imaging and intraoperative decision-making, offering a pathway toward more personalized, minimally invasive cancer care. Her innovative use of the drop-in gamma probe represents a significant technical achievement, positioning her as a rising leader in the development of next-generation surgical tools for primary prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of Using a Novel Drop-In Gamma Probe for 99mTc-PSMA-I&S–Guided Lymph Node Detection During Robot-Assisted Radical Prostatectomy for Primary Prostate Cancer
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago